Small high-density lipoprotein (HDL) subclasses are increased with decreased activity of HDL-associated phospholipase A₂ in subjects with prediabetes

Lipids. 2013 Jun;48(6):547-55. doi: 10.1007/s11745-013-3787-1. Epub 2013 Apr 2.

Abstract

Alterations in high-density lipoprotein (HDL) subclass distribution, as well as in the activities of HDL-associated enzymes, have been associated with increased cardiovascular disease (CVD) risk. HDL subclass distribution and the activities of HDL-associated enzymes remain unknown in prediabetic patients, a condition also associated with increased CVD risk. The aim of the present study was to assess any differences in HDL subclass distribution (using polyacrylamide gel electrophoresis) and in activities of HDL-associated enzymes between prediabetic (impaired fasting glucose, IFG, n = 80) and non-prediabetic subjects (n = 105). Subjects with prediabetes had significantly increased waist circumference, blood pressure and triacylglycerol (TAG) levels compared with subjects with fasting glucose levels <100 mg/dL (all p < 0.05). The proportion of small HDL3 over HDL cholesterol (HDL-C) was significantly increased in prediabetic subjects compared with their controls (p < 0.05). The activity of the anti-atherogenic HDL-associated lipoprotein-associated phospholipase A₂ (HDL-LpPLA₂) was significantly lower in subjects with prediabetes (p < 0.05), whereas the activity of paraoxonase 1 (using both paraoxon and phenyl acetate as substrates) did not significantly differ between subjects with or without prediabetes. In a stepwise linear regression analysis, the proportion of small HDL3 over HDL-C concentration was independently associated with the presence of prediabetes and with total cholesterol and TAG concentration (positively), as well as with HDL-C levels (negatively). We also observed a trend of increased small dense low-density lipoprotein cholesterol levels in prediabetic subjects compared with their controls. Subjects with IFG exhibit increased proportion of small HDL3 particles combined with decreased activity of the anti-atherogenic HDL-LpPLA₂.

MeSH terms

  • 1-Alkyl-2-acetylglycerophosphocholine Esterase / blood
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase / metabolism*
  • Adult
  • Apolipoprotein C-II / blood
  • Apolipoprotein C-II / metabolism
  • Apolipoprotein C-III / blood
  • Apolipoprotein C-III / metabolism
  • Aryldialkylphosphatase / blood
  • Aryldialkylphosphatase / metabolism
  • Blood Glucose / metabolism
  • Fasting / blood
  • Female
  • Greece / epidemiology
  • Humans
  • Lipoproteins, HDL / analysis
  • Lipoproteins, HDL / blood*
  • Lipoproteins, HDL / metabolism
  • Male
  • Middle Aged
  • Prediabetic State / blood*
  • Prediabetic State / enzymology*
  • Prediabetic State / epidemiology
  • Prediabetic State / metabolism
  • Risk Factors
  • Triglycerides / blood
  • Triglycerides / metabolism
  • Waist Circumference

Substances

  • Apolipoprotein C-II
  • Apolipoprotein C-III
  • Blood Glucose
  • Lipoproteins, HDL
  • Triglycerides
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
  • Aryldialkylphosphatase